» Articles » PMID: 38616919

Anal Self-exam is a Valuable Screening Tool for Anal Cancer in Sexual and Gender Minority Persons

Overview
Date 2024 Apr 15
PMID 38616919
Authors
Affiliations
Soon will be listed here.
References
1.
Deshmukh A, Suk R, Shiels M, Sonawane K, Nyitray A, Liu Y . Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015. J Natl Cancer Inst. 2019; 112(8):829-838. PMC: 7825484. DOI: 10.1093/jnci/djz219. View

2.
Nyitray A, McAuliffe T, Liebert C, Swartz M, Deshmukh A, Chiao E . The accuracy of anal self- and companion exams among sexual minority men and transgender women: a prospective analysis. Lancet Reg Health Am. 2024; 31:100704. PMC: 10910307. DOI: 10.1016/j.lana.2024.100704. View

3.
Palefsky J, Lee J, Jay N, Goldstone S, Darragh T, Dunlevy H . Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer. N Engl J Med. 2022; 386(24):2273-2282. PMC: 9717677. DOI: 10.1056/NEJMoa2201048. View

4.
Fein L, Cunha I, Wong A, Schlumbrecht M, Duthely L, Potter J . Low Perceived Anal Cancer Risk and Screening Utilization Among High-Risk Transgender Men and Women Living in an HIV / STI Epicenter. AIDS Behav. 2021; 25(7):2210-2218. DOI: 10.1007/s10461-020-03149-w. View

5.
Ayhan C, Bilgin H, Uluman O, Sukut O, Yilmaz S, Buzlu S . A Systematic Review of the Discrimination Against Sexual and Gender Minority in Health Care Settings. Int J Health Serv. 2019; 50(1):44-61. DOI: 10.1177/0020731419885093. View